General Information of the Compound
| Compound ID |
CP0385827
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2R)-2-[1-cyano-3-ethyl-8-[2-[4-(trifluoromethyl)phenyl]ethyl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-N-methyl-2-phenylacetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H28F3N5O
|
||||||||||||||||||
| Molecular Weight |
495.549
|
||||||||||||||||||
| Canonical SMILES |
CCc1nc(C#N)c2C(CCc3ccc(cc3)C(F)(F)F)N(CCn12)[C@@H](C(=O)NC)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H28F3N5O/c1-3-23-33-21(17-31)25-22(14-11-18-9-12-20(13-10-18)27(28,29)30)34(15-16-35(23)25)24(26(36)32-2)19-7-5-4-6-8-19/h4-10,12-13,22,24H,3,11,14-16H2,1-2H3,(H,32,36)/t22?,24-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
SAZBDJSIVFUWHP-SYIFMXBLSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1